|Last Price$82.38||Day Change (%)-0.74%|
|Open Price$83.02||Day Change ($)-0.61|
|Day Range82.31–83.35||52-Week Range64.64–88.83|
As of Fri 3/27/2015 5:14:00 PM | USD
Specialists On Call Appoints Hammad Shah as Chief Executive Officer
The wide-moat pharmacy benefit manager is still undervalued.
The wide-moat pharmacy benefit manager--which is currently rated 4 stars by Morningstar--was Berkshire's only new money purchase during the third quarter.
Pharmacy benefits manager Express Scripts is attractively priced given its ability to fend off competitors for years to come.
Warren Buffett’s Berkshire Hathaway had a shift in strategy in the fourth quarter as it unloaded most of its energy holdings to buy more of Deere and IBM.
These top investment managers put new money to work in several wide-moat names, including United Technologies.
Misunderstanding on private health insurance exchanges could mean opportunity for investors.
Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.
Express Scripts ESRX reported first-quarter results that beat our expectations. The company also increased its earnings-per-share guidance for the year, but more importantly to us, Express Scripts expects higher cash flow from operations in 2007 than it did previously. We're reviewing our model in ...